{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-077076","form_type":"8-K","ticker":"IRWD","cik":"0001446847","company_name":"IRONWOOD PHARMACEUTICALS INC","filed_at":"2023-06-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.903851+00:00","generated_at":"2026-06-13T13:51:30.852643+00:00","sec_items":["2.01","2.03","8.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Ironwood completes $1.15B tender offer for VectivBio, acquires ~97.6% of shares","bullets":["Tendered 59.3M shares represent ~94.4% plus 2.0M via guaranteed delivery (~97.6% total).","Offer price $17/share cash; total consideration ~$1.15B.","Borrowed $400M under Revolving Credit Agreement to fund portion.","Plans to delist VectivBio shares from Nasdaq and execute Swiss squeeze-out merger.","Ironwood appointed new directors to VectivBio board effective immediately."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-077076","json":"https://secwatch.observer/filing/0001104659-23-077076.json","markdown":"https://secwatch.observer/filing/0001104659-23-077076.md","text":"https://secwatch.observer/filing/0001104659-23-077076.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1446847/000110465923077076/0001104659-23-077076-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1446847/000110465923077076/tm2320339d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T13:51:30.852643+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"854302c20f305fc9756e345896ec4d8b3acc388d","claim":"IRONWOOD PHARMACEUTICALS INC incurred revolving credit of $400,000,000 with Wells Fargo Bank, N.A..","evidence_excerpt":"On June 29, 2023, Ironwood borrowed $400,000,000 under the Revolving Credit Agreement to fund a portion of the consideration paid to purchase the Shares in connection with the Offer.","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1446847/000110465923077076/0001104659-23-077076-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"revolving credit"},{"label":"Principal","value":"$400,000,000"},{"label":"Counterparty","value":"Wells Fargo Bank, N.A."},{"label":"Event","value":"incurrence"}],"fact_type":"debt_financing"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}